Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | SMPD2 | O60906 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.32 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.31 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | HRH1 | P35367 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.31 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL186682 | 1.00 | TP53 (0.35) | TP53MAPTSMPD2CHRNB2CHRNB4 | |
| SCHEMBL15050275 | 0.98 | TP53 (0.33) | TP53MAPTSMPD2CHRNB2CHRNB4 | |
| SCHEMBL15050278 | 0.98 | TP53 (0.33) | TP53MAPTSMPD2CHRNB2CHRNB4 | |
| SCHEMBL27277859 | 0.89 | HTR2A (0.40) | TP53SMPD2CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL7612000 | 0.87 | TDP1 (0.36) | ADRA2ACYP1A2ALDH1A1 | |
| SCHEMBL10982870 | 0.84 | ACE2 (0.41) | MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL17685567 | 0.80 | SMPD2 (0.38) | SMPD2 | |
| SCHEMBL755798 | 0.80 | FDPS (0.43) | TP53SMPD2PGRADRA2AADRA2B | |
| SCHEMBL9021302 | 0.80 | TP53 (0.35) | TP53MAPTCHRNB2CHRNB4CHRNA3 | |
| SCHEMBL2204496 | 0.80 | FDPS (0.43) | TP53SMPD2PGRADRA2AADRA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118439965-A | Method for synthesizing amino alcohol by using diethanolamine | 济宁无内新材料技术研发中心(有限合伙) | 2024-08-06 | — | — | CN | claimed |
| WO-2013092579-A2 | METHOD FOR PRODUCING ONE OR MORE COMPLEXING AGENTS, SELECTED FROM METHYLGLYCINEDIACETIC ACID, GLUTAMIC ACID DIACETIC ACID, AND SALTS THEREOF | BASF SE (DE) | 2013-06-27 | — | — | WO | claimed |
| US-20130165689-A1 | PROCESS FOR PREPARING ONE OR MORE COMPLEXING AGENTS SELECTED FROM METHYLGLYCINEDIACETIC ACID, GLUTAMIC ACID DIACETIC ACID AND SALTS THEREOF | BASF SE (DE) | 2013-06-27 | — | — | US | claimed |
| JP-4537580-B2 | — | — | 2010-09-01 | — | — | JP | claimed |
| EP-1114023-B1 | PROCESS FOR PREPARING CARBOXYLIC ACIDS | DOW AGROSCIENCES LLC (US) | 2004-05-26 | — | — | EP | claimed |
| JP-2002524548-A | — | — | 2002-08-06 | — | — | JP | claimed |
| US-20010008948-A1 | Process for preparing carboxylic acids | RINGER JAMES W (US) | 2001-07-19 | — | — | US | claimed |
| EP-1114023-A1 | PROCESS FOR PREPARING CARBOXYLIC ACIDS | Dow AgroSciences LLC (US) | 2001-07-11 | — | — | EP | claimed |
| US-6229045-B1 | CARBOXYLATION OF PRIMARY ALIPHATIC ALCOHOLS IN ALKALINE SOLUTION VIA CONTACTING WITH A CATALYST COMPRISING COBALT, COPPER, CERIUM, IRON, ZINC, AND/OR ZIRCONIUM | DOW AGROSCIENCES LLC | 2001-05-08 | — | — | US | claimed |
| WO-2000015601-A1 | PROCESS FOR PREPARING CARBOXYLIC ACIDS | DOW AGROSCIENCES LLC (US) | 2000-03-23 | — | — | WO | claimed |
| US-4143159-A | SKIN-CARE AGENTS CONTAINING HYDROXYALKYL CARBOXAMIDES AND PROCESS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1979-03-06 | — | — | US | claimed |
| EP-4743520-A1 | SEALING COMPOSITION BASED ON POLYURETHANE AND POLY(VINYL ACETAL) | Saint-Gobain Weber France (FR) | 2026-05-20 | — | — | EP | disclosed |
| WO-2025012260-A1 | SEALING COMPOSITION BASED ON POLYURETHANE AND POLY(VINYL ACETAL) | SAINT-GOBAIN WEBER FRANCE (FR) | 2025-01-16 | — | — | WO | disclosed |
| WO-2024226422-A1 | HELICASE DEGRADERS | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) | 2024-10-31 | — | — | WO | disclosed |
| CN-118439965-A | Method for synthesizing amino alcohol by using diethanolamine | 济宁无内新材料技术研发中心(有限合伙) | 2024-08-06 | — | — | CN | disclosed |
| US-5585391-A | Hydroxyl ions as unique therapeutic agents and compounds that modulate these ions, compositions employing these agents, therapeutic methods for using such agents and processes for preparing them | FHJ SCIENTIFIC, INC. (US) | 1996-12-17 | — | — | US | disclosed |
| US-5574050-A | Hydroxyl ions as unique therapeutic agents and processes for preparing them | FHJ SCIENTIFIC, INC. (US) | 1996-11-12 | — | — | US | disclosed |
| EP-0725636-A1 | HYDROXYL IONS AS UNIQUE THERAPEUTIC AGENTS AND COMPOUNDS THAT MODULATE THESE IONS, COMPOSITIONS EMPLOYING THESE AGENTS, THERAPEUTIC METHODS FOR USING SUCH AGENTS AND PROCESSES FOR PREPARING THEM | FHJ SCIENTIFIC, INC. (US) | 1996-08-14 | — | — | EP | disclosed |
| US-5514808-A | Hydroxyl ions as unique therapeutic agents and compounds that modulate these ions | FHJ SCIENTIFIC, INC (US) | 1996-05-07 | — | — | US | disclosed |
| WO-1995010272-A1 | HYDROXYL IONS AS UNIQUE THERAPEUTIC AGENTS AND COMPOUNDS THAT MODULATE THESE IONS, COMPOSITIONS EMPLOYING THESE AGENTS, THERAPEUTIC METHODS FOR USING SUCH AGENTS AND PROCESSES FOR PREPARING THEM | FHJ SCIENTIFIC, INC. (US) | 1995-04-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130165689-A1 | PROCESS FOR PREPARING ONE OR MORE COMPLEXING AGENTS SELECTED FROM METHYLGLYCINEDIACETIC ACID, GLUTAMIC ACID DIACETIC ACID AND SALTS THEREOF | GRIK1, DDC, CA1 | TP53 3733/4885MAPT 2792/4885SMPD2 4327/4885 |
| US-20010008948-A1 | Process for preparing carboxylic acids | ADH1A, ADH1C, ADH5 | TP53 2424/4885MAPT 3871/4885SMPD2 1176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.